v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2024 $ 12,536 $ 201,103,311 $ (182,110,999) $ 19,004,848
Balance (in shares) at Dec. 31, 2024 37,987,380      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 1,253,882 0 1,253,882
Issuance of common stock for consulting agreement $ 50 203,451 0 203,501
Issuance of common stock for consulting agreement (in shares) 150,000      
Issuance of common stock from at-the-market program, net $ 68 306,047 0 306,115
Issuance of common stock from at-the-market program, net (in shares) 205,350      
Issuances of common stock, net of issuance costs $ 2,111 6,919,908 0 6,922,019
Issuances of common stock, net of issuance costs (in shares) 6,396,787      
Issuance of pre-funded warrants $ 0 1,009,969 0 1,009,969
Issuance of warrants 0 2,150,771 0 2,150,771
Exercise of pre-funded warrants $ 233 (162) 0 71
Exercise of pre-funded warrants (in shares) 706,334      
Net loss $ 0 0 (8,488,967) (8,488,967)
Balance at Mar. 31, 2025 $ 14,998 212,947,177 (190,599,966) 22,362,209
Balance (in shares) at Mar. 31, 2025 45,445,851      
Balance at Dec. 31, 2024 $ 12,536 201,103,311 (182,110,999) 19,004,848
Balance (in shares) at Dec. 31, 2024 37,987,380      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss       (17,923,175)
Balance at Jun. 30, 2025 $ 15,390 215,978,568 (200,034,174) 15,959,784
Balance (in shares) at Jun. 30, 2025 46,633,362      
Balance at Mar. 31, 2025 $ 14,998 212,947,177 (190,599,966) 22,362,209
Balance (in shares) at Mar. 31, 2025 45,445,851      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 448,029 0 448,029
Issuance of common stock from at-the-market program, net $ 317 1,460,325 0 1,460,642
Issuance of common stock from at-the-market program, net (in shares) 960,511      
Issuances of common stock, net of issuance costs $ 0 50,000 0 50,000
Issuances of common stock, net of issuance costs (in shares) 0      
Issuance of warrants $ 0 1,073,089 0 1,073,089
Exercise of pre-funded warrants $ 75 (52) 0 23
Exercise of pre-funded warrants (in shares) 227,000      
Net loss $ 0 0 (9,434,208) (9,434,208)
Balance at Jun. 30, 2025 $ 15,390 215,978,568 (200,034,174) 15,959,784
Balance (in shares) at Jun. 30, 2025 46,633,362      
Balance at Dec. 31, 2025 $ 18,111 225,840,226 (216,606,504) 9,251,833
Balance (in shares) at Dec. 31, 2025 54,878,233      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 1,156,495 0 1,156,495
Issuance of common stock from at-the-market program, net $ 309 833,062 0 833,371
Issuance of common stock from at-the-market program, net (in shares) 937,420      
Net loss $ 0 0 (7,349,056) (7,349,056)
Balance at Mar. 31, 2026 $ 18,420 227,829,783 (223,955,560) 3,892,643
Balance (in shares) at Mar. 31, 2026 55,815,653      
Balance at Dec. 31, 2025 $ 18,111 225,840,226 (216,606,504) 9,251,833
Balance (in shares) at Dec. 31, 2025 54,878,233      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss       (17,099,631)
Balance at Jun. 30, 2026 $ 18,455 230,107,941 (233,706,135) (3,579,739)
Balance (in shares) at Jun. 30, 2026 55,921,806      
Balance at Mar. 31, 2026 $ 18,420 227,829,783 (223,955,560) 3,892,643
Balance (in shares) at Mar. 31, 2026 55,815,653      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 1,126,054 0 1,126,054
Issuance of common stock from at-the-market program, net $ 35 97,196 0 97,231
Issuance of common stock from at-the-market program, net (in shares) 106,153      
Issuance of warrants $ 0 1,054,908 0 1,054,908
Net loss 0 0 (9,750,575) (9,750,575)
Balance at Jun. 30, 2026 $ 18,455 $ 230,107,941 $ (233,706,135) $ (3,579,739)
Balance (in shares) at Jun. 30, 2026 55,921,806